US Flea Control and Heartworm Markets, December 2020

A new study from Brakke Consulting takes an in-depth look at flea, tick and heartworm products, the largest segment of the companion animal market.

”The flea control and heartworm preventatives market has been one of the most innovative areas in animal health, with a variety of new active ingredients and novel formulations,” said Lynn Fondon DVM MBA, Brakke Consulting Senior Consultant.  “Sales of flea control products continue to grow, and the newest generation of oral flea and tick products are transforming the landscape once again.”

The study, The US Flea Control and Heartworm Markets, profiles the veterinary and OTC markets for flea and tick products and heartworm preventatives, including veterinary product sales and pricing. The report includes detailed information on the introduction and subsequent performance of generic versions of the Frontline® and Advantage® flea and tick products.  It also provides a look at products launched this year, including Simparica Trio® and Bravecto Plus®; the launch of generic competitors to Revolution®; and the launch of Amazon’s house brand of fipronil spot-on. Additionally, parasiticides that are in the pipeline and expected to reach the US market in the next 2-3 years are discussed in the report.

The report – published annually by Brakke for over two decades – gathered information from a variety of sources, including published information, industry interviews and a survey of 335 small animal veterinarians and 500 pet owners.

The US Flea Control and Heartworm Markets report is available from Brakke Consulting for $7,995. For more information, interested companies should contact lfondon@brakkeconsulting.com.